COX11 Human Pre-designed siRNA Set A contains three designed siRNAs for COX11 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

COX14 Human Pre-designed siRNA Set A contains three designed siRNAs for COX14 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

COX15 Human Pre-designed siRNA Set A contains three designed siRNAs for COX15 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

COX17 Human Pre-designed siRNA Set A contains three designed siRNAs for COX17 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

COX18 Human Pre-designed siRNA Set A contains three designed siRNAs for COX18 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

COX19 Human Pre-designed siRNA Set A contains three designed siRNAs for COX19 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

COX20 Human Pre-designed siRNA Set A contains three designed siRNAs for COX20 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

COX4I1 Human Pre-designed siRNA Set A contains three designed siRNAs for COX4I1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

COX4I2 Human Pre-designed siRNA Set A contains three designed siRNAs for COX4I2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

COX5A Human Pre-designed siRNA Set A contains three designed siRNAs for COX5A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

COX5B Human Pre-designed siRNA Set A contains three designed siRNAs for COX5B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

COX6A1 Human Pre-designed siRNA Set A contains three designed siRNAs for COX6A1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

COX6A2 Human Pre-designed siRNA Set A contains three designed siRNAs for COX6A2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

COX6B1 Human Pre-designed siRNA Set A contains three designed siRNAs for COX6B1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

COX6B2 Human Pre-designed siRNA Set A contains three designed siRNAs for COX6B2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

COX6C Human Pre-designed siRNA Set A contains three designed siRNAs for COX6C gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

COX7A1 Human Pre-designed siRNA Set A contains three designed siRNAs for COX7A1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

COX7A2 Human Pre-designed siRNA Set A contains three designed siRNAs for COX7A2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

COX7A2L Human Pre-designed siRNA Set A contains three designed siRNAs for COX7A2L gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

COX7B Human Pre-designed siRNA Set A contains three designed siRNAs for COX7B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

COX7C Human Pre-designed siRNA Set A contains three designed siRNAs for COX7C gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

COX8A Human Pre-designed siRNA Set A contains three designed siRNAs for COX8A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CP Human Pre-designed siRNA Set A contains three designed siRNAs for CP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CPA1 Human Pre-designed siRNA Set A contains three designed siRNAs for CPA1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CPA2 Human Pre-designed siRNA Set A contains three designed siRNAs for CPA2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CPA3 Human Pre-designed siRNA Set A contains three designed siRNAs for CPA3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CPA4 Human Pre-designed siRNA Set A contains three designed siRNAs for CPA4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CPA5 Human Pre-designed siRNA Set A contains three designed siRNAs for CPA5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CPA6 Human Pre-designed siRNA Set A contains three designed siRNAs for CPA6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CPAMD8 Human Pre-designed siRNA Set A contains three designed siRNAs for CPAMD8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CPB1 Human Pre-designed siRNA Set A contains three designed siRNAs for CPB1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CPB2 Human Pre-designed siRNA Set A contains three designed siRNAs for CPB2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CPD Human Pre-designed siRNA Set A contains three designed siRNAs for CPD gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CPD-002 is an inhibitor for vascular endothelial growth factor receptor 2(VEGFR2), that inhibits angiogenesis through inhibition of VEGFR2/PI3K/AKT signaling pathway. CPD-002 exhibits anti-inflammatory activity and attenuates rheumatoid arthritis[1].

CPE Human Pre-designed siRNA Set A contains three designed siRNAs for CPE gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CPEB1 Human Pre-designed siRNA Set A contains three designed siRNAs for CPEB1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CPEB2 Human Pre-designed siRNA Set A contains three designed siRNAs for CPEB2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CPEB3 Human Pre-designed siRNA Set A contains three designed siRNAs for CPEB3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CPEB4 Human Pre-designed siRNA Set A contains three designed siRNAs for CPEB4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CPED1 Human Pre-designed siRNA Set A contains three designed siRNAs for CPED1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CPL207280 is an orally active GPR40/FFA1 agonist with an antidiabetic effect. CPL207280 can effectively enhance glucose-stimulated insulin secretion and improve glucose tolerance in MIN6 pancreatic β-cells as well as in healthy Wistar Han rats and diabetic rat models. CPL207280 can be used for the research of type 2 diabetes[1][2].

cPLA2α-IN-2 (Compound 122) is an inhibitor of cytosolic phospholipase A2α (cPLA2α)[1].

CPLANE1 Human Pre-designed siRNA Set A contains three designed siRNAs for CPLANE1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CPLX1 Human Pre-designed siRNA Set A contains three designed siRNAs for CPLX1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CPLX2 Human Pre-designed siRNA Set A contains three designed siRNAs for CPLX2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CPLX3 Human Pre-designed siRNA Set A contains three designed siRNAs for CPLX3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CPM Human Pre-designed siRNA Set A contains three designed siRNAs for CPM gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CPN-219, a next-generation hexapeptidic NMUR2 agonist, achieves a dose-dependent and selective activation of NMUR2 with an EC50 value of 2.2 nM[1].